GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » PB Ratio

Rohto Pharmaceutical Co (TSE:4527) PB Ratio : 2.89 (As of Apr. 27, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-27), Rohto Pharmaceutical Co's share price is 円3036.00. Rohto Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2023 was 円1,052.15. Hence, Rohto Pharmaceutical Co's PB Ratio of today is 2.89.

Good Sign:

Rohto Pharmaceutical Co Ltd stock PB Ratio (=2.77) is close to 1-year low of 2.74

The historical rank and industry rank for Rohto Pharmaceutical Co's PB Ratio or its related term are showing as below:

TSE:4527' s PB Ratio Range Over the Past 10 Years
Min: 1.51   Med: 2.37   Max: 4.2
Current: 2.88

During the past 13 years, Rohto Pharmaceutical Co's highest PB Ratio was 4.20. The lowest was 1.51. And the median was 2.37.

TSE:4527's PB Ratio is ranked worse than
75.25% of 1794 companies
in the Consumer Packaged Goods industry
Industry Median: 1.49 vs TSE:4527: 2.88

During the past 12 months, Rohto Pharmaceutical Co's average Book Value Per Share Growth Rate was 15.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 14.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 10.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 7.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Rohto Pharmaceutical Co was 14.60% per year. The lowest was 3.90% per year. And the median was 7.00% per year.

Back to Basics: PB Ratio


Rohto Pharmaceutical Co PB Ratio Historical Data

The historical data trend for Rohto Pharmaceutical Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co PB Ratio Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.47 2.42 2.16 2.36 3.02

Rohto Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.55 3.02 3.36 3.97 2.70

Competitive Comparison of Rohto Pharmaceutical Co's PB Ratio

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co's PB Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's PB Ratio falls into.



Rohto Pharmaceutical Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Rohto Pharmaceutical Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=3036.00/1052.152
=2.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Rohto Pharmaceutical Co  (TSE:4527) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Rohto Pharmaceutical Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co (TSE:4527) Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines